Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CE-5S: Sonothrombolysis in Stroke
NCT03290053Phase 3Terminated
- Sponsor
- Umeå University
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride in ischemic stroke, sponsored by Umeå University. Started Nov 2017; status: terminated.
02
Drugs
sulfur hexafluoride
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03290053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290053.